Gainers
- 9 Meters Biopharma, Inc. (NASDAQ:NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
- Grom Social Enterprises, Inc. (NASDAQ:GROM) rose 25.2% to $0.4199 in pre-market trading. Grom's Curiosity Ink Media announced that the company Secured the husband-wife writing team, Chelsea and Matt Giegerich, to pen the storyline for 'The Pirate Princess.'
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares rose 16.2% to $0.9763 in pre-market trading. Faraday Future Intelligent Electric shares gained around 10% on Monday after the company announced FF Top will dismiss its lawsuit against the company and its board of directors. The company also announced a new $100 million financing commitment.
- BIT Mining Limited (NYSE:BTCM) rose 15.4% to $0.30 in pre-market trading after declining around 9% on Monday.
- Bakkt Holdings, Inc. (NYSE:BKKT) rose 15.1% to $2.52 in pre-market trading. Bakkt Holdings recently appointed Chip Goodroe as its Chief Accounting Officer.
- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) rose 14.2% to $11.99 in pre-market trading.
- Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 13.2% to $2.31 in pre-market trading after gaining over 11% on Monday.
- ContraFect Corporation (NASDAQ:CFRX) rose 13% to $0.20 in pre-market trading. ContraFect, last month, said it continues to advance lead programs toward new clinical studies and expects to file with regulatory authorities later this year to initiate a study of intra-articular exebacase in chronic or recurrent prosthetic joint infections.
- BitNile Holdings, Inc. (NYSE:NILE) rose 12.1% to $0.2075 in pre-market trading.
- CorpHousing Group Inc. (NASDAQ:CHG) rose 10.3% to $1.80 in pre-market trading. CorpHousing Group posted Q2 EPS of $0.04.
- Helix Energy Solutions Group, Inc. (NYSE:HLX) rose 9.6% to $4.08 in pre-market trading. Helix Energy Solutions recently announced two-year contract extension with Petrobras for Siem Helix 2.
- TechnipFMC plc (NYSE:FTI) rose 9.5% to $8.84 in pre-market trading. TechnipFMC was recently awarded a significant subsea contract for Shell's North Sea Development.
- Akebia Therapeutics, Inc. (NASDAQ:AKBA) rose 8.3% to $0.3333 in pre-market trading. Akebia Therapeutics, last month, announced initial findings from an investigator-sponsored study evaluating vadadustat for Acute Respiratory Distress Syndrome (ARDS) with COVID-19 and hypoxemia.
- Geron Corporation (NASDAQ:GERN) rose 5.8% to $2.39 in pre-market trading. Geron, last month, dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).
- PureCycle Technologies, Inc. (NASDAQ:PCT) rose 5.8% to $8.89 in pre-market trading.
- I-Mab (NASDAQ:IMAB) rose 5.5% to $4.80 in pre-market trading. I-Mab recently announced approval from China CDE to initiate Phase 3 registrational study of lemzoparlimab in combination with azacitidine in higher-risk myelodysplastic syndrome.
